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Abstract 
AIM: In recent decades, despite various types of cancer inflicting many people worldwide, the existing therapies 
are not satisfactory and have many side effects. The present study was conducted to optimise the synthesis of 
novel alginate-CuO nanocomposite with utmost anticancer activity. 
METHODS: In this study, 9 nanocomposites were designed using Taguchi method and three factors including 
copper oxide nanoparticles, alginate biopolymer and stirring times were assessed at three different levels. The 
anticancer activity of the synthesised nanocomposites was evaluated on the MCF-7 cell line using the MTT 
method. Using the Qulitek-4 software, we determined the optimum conditions for the synthesis of alginate-CuO 
nanocomposite with the highest anticancer activity. 
RESULTS: The results indicated that all three factors (copper oxide, alginate and stirring time) were effective on 
the anticancer activity of the alginate-CuO nanocomposite. Also, the nanocomposite produced under the 
conditions of experiment 9 (8 mg/ml of copper oxide, 2 mg/ml of alginate and 60 min of stirring time) provided the 
highest growth inhibition rate as 75.63% against cancer cells.  
CONCLUSION: The synthesised alginate-copper oxide nanocomposites in this study showed a significant 
anticancer effect. Therefore, the synthesised nanocomposite under optimal conditions can be used in the design 
of new anticancer drugs. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Despite the synthesis of numerous new drug 
compounds in recent decades, no effective and 
definitive treatment has been still provided for some 
diseases such as autoimmune diseases [1], [2], 
microbial resistance [3], [4], AIDS [5], chronic pains 
[6], [7], [8] and cancer [9], [10]. Cancer is one of 
today’s common diseases, which is caused by the 
uninhibited proliferation of cells. The number of people 
affected by different types of cancer and the resulting 
deaths is increasing every year [11], [12]. Some of the 
factors involved in increasing the risk of cancer 
include new lifestyles, increased consumption of 
unhealthy foods, increased elderly population, and 
tobacco and alcohol consumption [13]. Despite the 
prevalence of various types of cancer, the current 
anticancer compounds are not responsive and have 
some disadvantages and problems. Increased drug 
resistance, lack of distinction between cancer cells 
and normal cells, severe side effects and high costs 
seem to be some of the current common anticancer 
drug problems. Hence, much effort is needed to find 
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new anticancer compounds in the view of the 
increasing growth of this disease. The researchers 
have recently focused on the use of nanotechnology 
for the synthesis of various anticancer compounds 
and reported an optimal anticancer activity for a 
variety of nanoparticles. 
Copper oxide nanoparticles have recently 
received much attention because of their 
biocompatibility and anticancer properties. Despite 
few studies reported in this regard, these studies have 
shown that copper oxide nanoparticles have a 
potential ability as an anticancer agent [14], [15]. In 
recent years, the use of metal nanoparticles in the 
structure of nanocomposites has expanded rapidly. 
Some of the advantages of employing nanoparticles in 
the form of nanocomposites include the easy control 
of the metals concentrations, low costs of the 
production process and most importantly the 
prevention of the agglomeration of nanoparticles. 
Different compounds are used as the substrate for the 
synthesis of nanocomposites. In this regard, polymers 
are one of the most important ones [16]. Due to 
biocompatibility and biodegradability, alginate 
biopolymer has come to the focus of attention for 
various biological applications. This biopolymer is a 
polysaccharide composed of two subunits of 
mannuronic acid and glucuronic acid [17]. Polymer 
alginate is usually synthesised in two forms; chemical 
and microbial. Microbial alginate can be synthesized 
by fungi and bacteria. Bacterial alginate is produced 
using Azotobacter and Pseudomonas. Also, bacterial 
biosynthesis of alginate can provide compounds with 
defined chemical structures and physical properties. 
Recent developments in the relative ease of modifying 
bacteria and regulating alginate biosynthesis in 
bacteria may empower the production of alginate with 
customised features and extensive biomedical 
applications [18]. 
Although much research has been done on 
the use of nanocomposites as antimicrobial agents, 
their anticancer properties have been less noticeable. 
The present study was conducted to use copper oxide 
nanoparticles in the form of alginate – copper oxides 
nanocomposite for the synthesis of novel 
nanocomposite with the most favourable anticancer 
activity using the Taguchi method. 
 
 
Material and Methods 
 
The copper oxide nanoparticles were 
synthesised using the coprecipitation method by an 
approach introduced in the previous study. Alginate 
biopolymer was synthesized using Azotobacter 
vinelandii IBRC 10786 prepared from Iranian 
Biological Resource Center [19]. 
Aimed at determining the optimal conditions 
for the synthesis of nanocomposites with the highest 
anticancer activity, 9 experiments were designed by 
Taguchi method with different amounts of biopolymer 
and nanoparticles at different stirring times using the 
Qulitek-4 software (Table 1). Thus, solutions of copper 
oxides nanoparticles (2, 4, and 8 mg/ml) and alginate 
biopolymer (0.5, 1, and 2 mg/ml) were prepared at 3 
levels separately. The solution containing the 
nanoparticles was then added to the biopolymer 
solution drop by drop and combined with the in situ 
synthesis method at stirring times of 30, 60 and 90 
min. After stirring, the solutions containing the 
nanocomposite were placed in a 40 °C oven as long 
as the white powder of the nanocomposite is formed. 
The MTT method was used to determine the 
anticancer activity of 9 nanocomposites synthesised in 
this study. To do so, the cells of the Michigan Cancer 
Foundation-7 (MCF-7) line were cultured in the 
Dulbecco’s Modified Eagle’s Medium (DMEM) 
medium in the presence of 5% CO2 and 95% moisture 
at 37°C. Then, 180 μl of cell suspension containing 5 
× 10
4
 cells were added to each well plate to be 
cultured for 24 h. About 20 μl of the synthesised 
nanocomposites in 9 experiments was added to each 
well, and the cells were treated for 72 h. After adding 
20 μl of the MTT solution to each well and performing 
MTT test steps, the absorption rate of each plate was 
determined by ELISA reader. All experiments of this 
study included three tests carried out in triplicate. 
Finally, the inhibition rate of MCF-7 cancer cells 
growth by the studied nanocomposites was 
determined using the proposed relation [20]. 
 
ODt: optical density of treated cells 
ODc: optical density of control cells 
 
 
Results 
 
Based on Taguchi method, nine 
nanocomposites were synthesised using factors 
including the content of copper oxide nanoparticles, 
alginate biopolymer and different stirring times. 
Synthesised nanocomposites were added to the MCF-
7 cancer cells to identify the most potent anticancer 
compound (Table 1). The nanocomposite produced 
using 8 mg/ml of copper oxide, 2 mg/ml of alginate 
and the stirring time of 60 min (Test 9) showed the 
highest inhibitory growth rate of 75.63% against the 
cancer cells. The lowest inhibition of cell growth was 
related to the nanocomposite synthesized under the 
conditions of experiment 1 (2 mg/ml of copper oxide, 
0.5 mg/ml of alginate, and the stirring time of 30 min), 
which was 42.62%. 
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Table 1: Taguchi design of experiments and results of 
anticancer activity of alginate-copper oxide 
bionanocomposites 
 
Experiment 
CuO (mg/ml) Alginate (mg/ml) Stirring time (min) Cell growth 
inhibition 
(%) 
2 4 8 0.5 1 2 30 60 90 
1  2   0.5   30  42.62 
2  2   1   60  55.39 
3  2   2   90  46.11 
4  4   0.5   60  66.38 
5  4   1   90  72.30 
6  4   2   30  68.36 
7  8   0.5   90  55.14 
8  8   1   30  70.42 
9  8   2   60  75.63 
 
The effects of the factors of copper oxide 
nanoparticles, alginate biopolymer and different 
stirring times at different levels on the growth inhibition 
rate of the MCF-7 cells by alginate-copper oxide 
nanocomposites are presented in Table 2. The 
second level in all three examined factors showed the 
highest effect in inhibiting the growth of cancer cells. 
The effects of factors, including copper oxide 
nanoparticles, alginate biopolymer and the stirring 
time in the structure of alginate-copper oxide 
nanocomposite on the inhibitory effect on the cancer 
cell growth were 69.01%, 66.04% and 65.80%, 
respectively. 
Table 2: Effect of different levels of factors on the anticancer 
activity of alginate-copper oxide bionanocomposite 
Factors  Level 1 Level 2 Level 3 
CuO  48.04 69.01 67.06 
Alginate  54.71 66.04 63.37 
Stirring time  60.47 65.80 57.85 
 
Table 3 shows the interactions among the 
studied factors (copper oxide nanoparticles, alginate 
biopolymer and the stirring time) at different levels. 
The third level of alginate biopolymer and the second 
level of the stirring time had the highest interaction 
effect on inhibiting the growth of cancer cells by a 
value of 58.57%. The copper oxide nanoparticles at 
the third level and the stirring time at the second level 
showed a significant interaction in inhibiting the cells 
growth by 22.34%. The interaction between the third 
levels of copper oxide nanoparticles and alginate 
biopolymer by 10.37% revealed the lowest severity of 
the effect on reducing the growth of MCF-7 cells. 
Table 3: The interactions effects of studied factors on 
anticancer activity of alginate-copper oxide bionanocomposite 
Interacting factor pairs Column Severity Index (%) Optimum conditions 
Alginate × Stirring time 2 × 3 58.75 [3, 2] 
CuO × Stirring time 1 × 3 22.34 [3, 2] 
CuO × Alginate 1 × 2 10.37 [3, 3] 
 
Analysis of the variance of copper oxide 
nanoparticles, alginate biopolymer and the stirring 
time on the inhibition of growth of the MCF-7 cancer 
cells is shown in Table 4. Copper oxide nanoparticles 
(68.75%) and the stirring time (6.60%) showed the 
highest and lowest effect on inhibiting the cells 
growth, respectively. Alginate biopolymer was also 
effective in reducing the growth of cancer cells by 
16.42%. 
Table 4: Analysis of variance for anticancer activity of alginate-
copper oxide bionanocomposite 
Factors DOF Sum of Squares Variance F-Ratio (F) Pure Sum Per cent 
(%) 
CuO 2 805.57 402.78 34.44 782.18 68.75 
Alginate 2 210.23 105.11 8.99 186.84 16.42 
Stirring time 2 98.49 49.25 4.21 75.10 6.60 
 
The optimal conditions for the synthesis of 
alginate-copper oxide nanocomposites with the 
highest anticancer activity were predicted using the 
Taguchi method (Table 5). Based on the obtained 
results, the second levels of the factors of copper 
oxide nanoparticles, alginate biopolymer and the 
stirring time had the highest role in improving the 
inhibition of cancer cell growth by 7.64%, 4.66% and 
4.43% contribution, respectively. Due to the mean 
growth inhibition rate of MCF-7 cells under different 
conditions (61.37%) and the reduced growth rate at 
optimal conditions (16.73%), it is expected that the 
growth of cancer cells will be inhibited as 78.10% 
under the optimal conditions recommended for the 
synthesis of nanocomposites. 
Table 5: Prediction of optimal conditions for the synthesis of 
alginate-copper oxide bionanocomposite with maximum 
anticancer activity 
Factors Level Contribution 
CuO  2 7.64 
Alginate 2 4.66 
Stirring time 2 4.43 
The total contribution from all factors 16.73 
Current grand average of performance 61.37 
Cell growth inhibition at optimum condition 78.10 
 
 
 
Discussion 
 
The results indicated that all synthesised 
nanocomposites had a desirable anticancer activity. 
Also, all the studied factors (copper oxide 
nanoparticles, alginate biopolymer and stirring time) 
were effective on the anticancer activity of alginate-
copper oxide nanocomposite. In agreement with the 
results obtained, previous studies have also reported 
the anticancer activity of copper oxide nanoparticles 
and the nanocomposites containing those [21], [22], 
[23]. Jeronsia et al., [22] synthesised the copper oxide 
nanoparticles using the coprecipitation method and 
evaluated their anticancer activity at different levels 
against the MCF-7 cell line. According to their reports, 
with increasing dose, the anticancer activity of 
nanoparticles would increase. 
The placement of nanoparticles in the 
nanocomposite structure improves their structural 
properties, prevents their agglomeration and 
increases their contact surface [19]. The sum of the 
factors mentioned above can be effective in improving 
the anticancer activity of nanocomposites. The 
mechanism of the effect of nanoparticles and the 
nanocomposites containing them on cancer cells and 
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how to differentiate them from other cells is not 
exactly known. In this regard, Azizi et al., [24] 
synthesised a biocompatible nanocomposite using 
albumin and copper oxide nanoparticles. The 
anticancer properties of synthesised nanocomposites 
against breast cancer cells were studied by MTT 
method. They indicated that anticancer activity of 
albumin-copper oxide nanocomposite is significantly 
improved compared to the copper oxide 
nanoparticles. Also, ROS production was significantly 
higher in nanocomposite treated cells. 
ROS may provide an appropriate explanation 
for the selective toxicity of nanoparticles against 
cancer cells [25]. ROS and various signalling 
molecules are mainly found more in cells with a high 
proliferation such as cancerous cells because of their 
high metabolic rate compared to the normal cells. In 
the treatment of cancer cells, the nanoparticles react 
with chemicals and the signalling molecules 
surrounding them with a high rate, leading to the 
increased production of the ROS. By increasing the 
amount of ROS, the intensity of oxidative stress 
increases in the cell, which ultimately leads to 
apoptosis. However, ROS is also produced in the 
treatment of normal cells using the nanoparticles, but 
their production rate is relatively low in the normal 
cells compared to cancer cells since the normal cells 
have lower amounts of ROS and less signalling 
molecules. Therefore, the oxidative stress may not be 
sufficient to kill the cell, and as a result, they show a 
relatively low response to toxicity. Hence, the 
mentioned mechanism may be the main contributor to 
the selective toxicity of nanoparticles for cancer cells 
[26]. 
In this study, the Taguchi method was used to 
determine the optimum conditions for the synthesis of 
alginate-copper oxide nanocomposite with the highest 
anticancer ability considering its applied advantages 
in reducing the cost, time and the optimal predictive 
power. The findings of this study suggested that the 
alginate-copper oxide nanocomposite has an 
anticancer effect on the MCF-7 cancer cells at low 
concentrations. Moreover, these findings provided a 
new perspective on the use of nanocomposites in 
cancer treatment. Thus, they can be used to combat 
all types of cancers by performing more thorough 
studies. Also, animal and clinical studies of alginate-
copper oxide nanocomposite and its mechanisms of 
action are recommended for further studies. 
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